Sounds to me like it is progressing extremely well, they are intending to do the full 72 patient trial based on current results.
It’s not cheap to run a trial like this so the fact it is continuing is a big plus. It does have steps that do have to be followed hence the independent review.
Very promising.
- Forums
- ASX - By Stock
- IHL
- Ann: Independent data review commences for Ph 2 trial psilocybin
Ann: Independent data review commences for Ph 2 trial psilocybin, page-4
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)